Sumitomo Mitsui Trust Group
CELL

Sumitomo Mitsui Trust Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-351,213
Closed -$172K – 1171
2023
Q2 		$172K Hold
351,213
– – ﹤0.01% 1126
2023
Q1 		$407K Sell
351,213
-21,152
-6% -$38.7K ﹤0.01% 1083
2022
Q4 		$998K Sell
372,365
-16,427
-4% -$43.3K ﹤0.01% 1027
2022
Q3 		$1.11M Sell
388,792
-7,602
-2% -$32.3K ﹤0.01% 1017
2022
Q2 		$1.97M Sell
396,394
-16,809
-4% -$88.1K ﹤0.01% 955
2022
Q1 		$2.94M Sell
413,203
-32,749
-7% -$271K ﹤0.01% 906
2021
Q4 		$8.11M Buy
445,952
+117,900
+36% +$2.54M ﹤0.01% 791
2021
Q3 		$6.42M Buy
328,052
+191,308
+140% +$7.28M ﹤0.01% 821
2021
Q2 		$6.13M Buy
136,744
+59,679
+77% +$2.77M ﹤0.01% 838
2021
Q1 		$3.87M Buy
77,065
+8,423
+12% +$574K ﹤0.01% 864
2020
Q4 		$6.14M Buy
+68,642
New +$5.77M ﹤0.01% 818

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sumitomo Mitsui Trust Group's CELL Position: Q3 2023 in Review

Sumitomo Mitsui Trust Group sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 351,213 shares — an estimated $172K sold.

Sumitomo Mitsui Trust Group first reported a position in CELL in Q4 2020 and held it in 11 quarters. The position peaked at $8.11M in Q4 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Sumitomo Mitsui Trust Group reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 351,213 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $172K.
  • Sumitomo Mitsui Trust Group first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Sumitomo Mitsui Trust Group's PhenomeX Inc. Common Stock position peaked at $8.11M in Q4 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2023, filed 30 Oct 2023.